Key takeaways:
Telmisartan (Micardis) treats high blood pressure and helps prevent heart problems in certain groups of people. It’s also used off-label to treat kidney problems in people with diabetes. It’s part of the angiotensin II receptor blocker (ARB) medication class.
Your telmisartan dosage will depend on what you’re using it for. It usually ranges from 40 mg to 80 mg once daily.
Telmisartan is available as a lower-cost generic. You can find generic telmisartan tablets for up to 80% off at certain pharmacies with a free GoodRx discount.
Telmisartan (Micardis) is an oral medication that’s FDA approved to treat high blood pressure (hypertension). It’s part of a group of medications known as angiotensin II receptor blockers (ARBs). It’s also approved to lower the risk of major health problems (like heart attack and stroke) in some adults who are over 55 years old.
If you’re prescribed telmisartan, it’s important to follow the dosing instructions from your healthcare provider. Understanding why your dose might be increased or decreased can also be helpful. Here, we’ll cover what you need to know about telmisartan dosages.
Telmisartan is available as 20 mg, 40 mg, and 80 mg oral tablets. The typical telmisartan dosage for adults usually ranges from 40 mg to 80 mg daily. Your specific dose will depend on what you’re taking it for and how your body responds to the medication. It can be taken with or without food.
Below, we’ll discuss the manufacturer’s recommendations for telmisartan dosages. But if your healthcare provider prescribes something different, don’t be alarmed. Talk to them to make sure you understand how to take your dose.
Telmisartan hasn’t been studied in children. So kids usually shouldn’t take telmisartan.
If you’re taking telmisartan to lower your blood pressure, you may start out at 40 mg once daily. If your blood pressure remains high, your healthcare provider could increase your dose up to 80 mg once daily. On the other hand, if telmisartan 40 mg lowers your blood pressure too much, your provider may decrease your dose.
Your blood pressure should go down significantly within 2 weeks of starting telmisartan. But it can take up to 4 weeks to see the full effects.
Telmisartan is also FDA approved to decrease the risk of cardiovascular (CV) events in adults who are at least 55 years old and are at high risk for CV events. CV events are serious health problems that affect the blood vessels or heart. This includes heart attack or stroke.
Health conditions that put you at high risk for CV events include:
Previous stroke or “mini-stroke”
Diabetes with major damage to organs in the body including the eye, kidney, or heart
The recommended telmisartan dosage for this group of people is 80 mg once daily.
There’s a large amount of research showing that ARBs help slow down the progression of kidney problems in people with diabetes (diabetic nephropathy). Diabetic nephropathy is most likely to happen if you have diabetes with uncontrolled blood sugar. If it’s not managed well, it can lead to major kidney damage.
Many studies show that telmisartan has a beneficial effect on kidney function in people with diabetes. The telmisartan doses used in these studies were between 40 mg to 80 mg once daily.
Telmisartan isn’t FDA approved for diabetic nephropathy. But for people with diabetic nephropathy and hypertension, ARBs are considered a first-choice medication by the major international guideline on this topic. What’s more, ARBs may also be considered for people who have diabetic nephropathy and normal blood pressure.
There’s no specific telmisartan dosage adjustments for people with liver and kidney problems. But since telmisartan is metabolized (broken down) by the liver, your healthcare provider may monitor your liver function more closely (or start you at a lower telmisartan dosage) if you have existing liver problems.
The same is true for people with kidney problems, as there’s no recommended dosage adjustment for kidney problems. ARBs like telmisartan can protect the kidneys, but in rare cases they can make kidney problems worse. So if you have existing kidney disease, talk to your provider before starting telmisartan. They may recommend starting with a lower dose, or monitoring your kidney function more closely.
Keep in mind: Telmisartan may be taken with other medications that lower blood pressure. If your blood pressure drops too low, you may need a lower telmisartan dose.
If you miss a dose of telmisartan, take it right when you remember. But if it’s close to the time of your next scheduled dose, you’ll want to wait. This means you’ll skip your missed dose, and resume taking telmisartan with the next scheduled dose.
Never take two doses at once to make up for a missed dose. If you’re having trouble remembering to take telmisartan, there are a few helpful strategies you can use. For example, setting a reminder on your online calendar to take telmisartan and using a pill organizer can help.
If you take too much telmisartan, let your healthcare provider know right away. Taking too much telmisartan can cause dizziness, low blood pressure, and a fast heartbeat.
In some cases, these side effects can be managed at home. But in other scenarios, they can be more serious. If you’re having blurry vision, severe dizziness, or weakness, you may need emergency care. In this case, you’ll want to call Poison Control at 1-800-222-1222 or seek emergency medical care.
Telmisartan is available as a lower-cost generic tablet. GoodRx may be able to help you save up to 80% off the average retail price of a one-month supply of telmisartan 80 mg. Telmisartan's price at certain pharmacies may be as low as $11.00 with a free GoodRx discount.
Telmisartan is an ARB that treats hypertension. It can also help prevent heart attack, stroke, and death in certain groups of older adults. And it’s used off-label in diabetic nephropathy. Telmisartan doses range from 40 mg to 80 mg in most cases. It’s taken once a day.
Aurobindo Pharma Limited. (2023). TELMISARTAN - telmisartan tablet [package insert].
Dézsi, C. A. (2016). The different therapeutic choices with ARBs. Which one to give? When? Why?American Journal of Cardiovascular Drugs.
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. (2022). Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney International.
Nakamura, T., et al. (2007). Comparison of renal and vascular protective effects between Telmisartan and Amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency. Hypertension Research.
Ritz, E.,, et al. (2010). Renal protection in diabetes: Lessons from ONTARGET. Cardiovascular Diabetology.
Yusuf, S., et al. (2008). Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet.
Yusuf, S., et al. (2008). Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England Journal of Medicine.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.